Compare Charles River Laboratories Intl. Inc (CRL) vs Vertiv Holdings Co (VRT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Charles River Laboratories Intl. Inc vs Vertiv Holdings Co — how do they compare? Charles River Laboratories Intl. Inc trades at $286.25 (market cap $13.46B), while Vertiv Holdings Co trades at $293.73 (market cap $108.49B). The key difference: Vertiv Holdings Co is far larger — about 8.1× Charles River Laboratories Intl. Inc's market cap, and Vertiv Holdings Co pays a 0.09% dividend while Charles River Laboratories Intl. Inc pays none. Which is the better fit depends on your goals.
| CRL | VRT | |
|---|---|---|
Market Cap | $13.46B | $108.49B |
Sector | Health | Technology |
52-Week High | $282.00 | $376.23 |
52-Week Low | $145.57 | $121.82 |
Enterprise Value | $16.30B | $108.72B |
Dividend Yield | — | 0.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Charles River Laboratories (CRL) trades at $277.00, up 3.56% on the day and near its 52-week high of $277.07, reflecting strong bullish momentum. The stock exhibits positive technical signals with moving averages indicating an uptrend, though oscillators suggest overbought conditions. Fundamentally, the company reported Q2 2026 EPS of $3.02, beating estimates, and raised full-year guidance, yet faces profitability challenges with a negative net income margin of -5.96% and elevated valuation ratios like a P/E of 684.85. Recent news highlights improved biotech demand and institutional buying interest.
The outlook for CRL is cautiously optimistic, driven by earnings beats and raised guidance, but high valuation and weak profitability pose risks. Investment opportunity lies in sustained demand for drug development services, while risks include margin pressure, debt levels, and sensitivity to biotech funding cycles. The stock's proximity to all-time highs warrants monitoring for pullbacks.
Vertiv (VRT) trades at $297.49, up 10.14% in the last 24 hours, reflecting strong momentum driven by AI infrastructure demand. The stock exhibits a bullish technical trend with key resistance near $293 and support at $270. Fundamentally, the company shows robust growth with revenue rising to $10.23B in 2025 and net income reaching $1.33B, supported by a high ROE of 43.94%. Recent earnings beats and a consensus analyst price target of $386.58 highlight positive sentiment, though elevated valuation ratios like a P/E of 63.76 warrant caution.
The outlook for VRT remains positive due to its strategic position in the AI data center market, with projected revenue growth to $11.5B in 2026. However, risks include high valuation multiples, ongoing legal investigations, and dependence on tech sector capital expenditure cycles. Investors should weigh the growth potential against these factors, with analyst consensus strongly favoring a buy rating.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Charles River Laboratories Intl. Inc
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Read more on CRL →About Vertiv Holdings Co
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →
